Delivering a novel cell free therapy to improve stroke outcomes

Stroke is a crippling disease with very few treatment options. Nano-sized packages released by stem cells called exosomes contain signalling molecules that can initiate repair and regeneration, have anti-inflammatory properties and possess fewer limitations than their parent cell. Thus, exosomes offer great therapeutic hope for stroke patients. This project will test whether exosomes isolated from human placenta-derived stem cells can improve stroke-induced brain damage and functional impairment.